Health Care [ 12/12 ] | Pharmaceuticals [ 66/74 ]
NYSE | Common Stock
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals.
It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands.
The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations.
Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 8, 24 | 0.30 Increased by +66.67% | 0.24 Increased by +25.00% |
| May 8, 24 | 0.34 Decreased by -24.44% | 0.26 Increased by +30.77% |
| Feb 26, 24 | 0.08 Decreased by -57.89% | 0.11 Decreased by -27.27% |
| Nov 7, 23 | 0.18 Decreased by -10.00% | 0.12 Increased by +50.00% |
| Aug 7, 23 | 0.18 Decreased by -50.00% | 0.05 Increased by +260.00% |
| May 9, 23 | 0.45 Increased by +25.00% | 0.29 Increased by +55.17% |
| Feb 21, 23 | 0.19 Decreased by -9.52% | 0.13 Increased by +46.15% |
| Nov 8, 22 | 0.20 Increased by +5.26% | 0.16 Increased by +25.00% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | 1.03 B Decreased by -3.56% | 364.00 M Increased by +133.21% | Increased by +35.34% Increased by +134.44% |
| Jun 30, 24 | 1.18 B Increased by +12.02% | -50.00 M Increased by +48.45% | Decreased by -4.22% Increased by +53.98% |
| Mar 31, 24 | 1.21 B Decreased by -4.14% | 32.00 M Decreased by -68.93% | Increased by +2.66% Decreased by -67.59% |
| Dec 31, 23 | 1.03 B Increased by +4.76% | -141.00 M Decreased by -161.11% | Decreased by -13.62% Decreased by -149.25% |
| Sep 30, 23 | 1.07 B Increased by +3.89% | -1.10 B Decreased by -2.14 K% | Decreased by -102.62% Decreased by -2.05 K% |
| Jun 30, 23 | 1.06 B Decreased by -10.20% | -97.00 M Decreased by -340.91% | Decreased by -9.18% Decreased by -390.96% |
| Mar 31, 23 | 1.26 B Increased by +2.61% | 103.00 M Increased by +101.96% | Increased by +8.19% Increased by +96.82% |
| Dec 31, 22 | 988.00 M Decreased by -11.23% | -54.00 M Increased by +44.33% | Decreased by -5.47% Increased by +37.29% |